Latest Transactions

Jul 2018
  • Allergy Therapeutics plc
  • Secondary Offering
  • Financial Adviser, Nominated Adviser and Broker

£10.6 million

Jun 2018
  • LoopUp Group plc
  • Reverse Takeover of MeetingZone Group and £50 million Secondary Offering
  • Lead Financial Adviser, Nominated Adviser and Joint Bookrunner

£61.4 million

Apr 2018
  • Diurnal Group plc
  • Secondary Offering
  • Joint Broker and Joint Bookrunner

£10.5 million


“The Panmure team did an excellent job throughout our recent fund raise.  We were impressed by their advisory and distribution capabilities, with strong institutional access both in the UK and US.”

We are thrilled to have been the first tech IPO post Brexit and are grateful to the excellent team at Panmure Gordon who guided us to such a positive outcome.

“We would like to thank the Panmure team for their hard work and dedication to achieve a positive result for Eland Oil & Gas on a very tight timetable. To be able to generate new institutional demand, upscale the fundraise and place the stock at a premium is testament to the strength of their resources offering.”

“Since appointment, Panmure’s commitment and willingness to understand the Company’s business and strategy has contributed to Allergy achieving its corporate goals and increasing shareholder value. Panmure’s execution of our two transactions has been first-class, connecting us with new institutional investors while effectively managing and supporting the existing shareholder base. The Healthcare team has demonstrated its extensive knowledge of the sector throughout.”

Hear From More Happy Clients